These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 17804720)
1. Requirement for Rac1 in a K-ras induced lung cancer in the mouse. Kissil JL; Walmsley MJ; Hanlon L; Haigis KM; Bender Kim CF; Sweet-Cordero A; Eckman MS; Tuveson DA; Capobianco AJ; Tybulewicz VL; Jacks T Cancer Res; 2007 Sep; 67(17):8089-94. PubMed ID: 17804720 [TBL] [Abstract][Full Text] [Related]
2. The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis. Zhou C; Licciulli S; Avila JL; Cho M; Troutman S; Jiang P; Kossenkov AV; Showe LC; Liu Q; Vachani A; Albelda SM; Kissil JL Oncogene; 2013 Feb; 32(7):903-9. PubMed ID: 22430205 [TBL] [Abstract][Full Text] [Related]
3. K-Ras mediated murine epidermal tumorigenesis is dependent upon and associated with elevated Rac1 activity. Samuel MS; Lourenço FC; Olson MF PLoS One; 2011 Feb; 6(2):e17143. PubMed ID: 21358804 [TBL] [Abstract][Full Text] [Related]
4. Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice. Zandvakili I; Davis AK; Hu G; Zheng Y PLoS One; 2015; 10(6):e0127923. PubMed ID: 26030593 [TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression. Stallings-Mann ML; Waldmann J; Zhang Y; Miller E; Gauthier ML; Visscher DW; Downey GP; Radisky ES; Fields AP; Radisky DC Sci Transl Med; 2012 Jul; 4(142):142ra95. PubMed ID: 22786680 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras. Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854 [TBL] [Abstract][Full Text] [Related]
7. Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo. Wang Z; Pedersen E; Basse A; Lefever T; Peyrollier K; Kapoor S; Mei Q; Karlsson R; Chrostek-Grashoff A; Brakebusch C Oncogene; 2010 Jun; 29(23):3362-73. PubMed ID: 20383193 [TBL] [Abstract][Full Text] [Related]
8. Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis. Bassères DS; Ebbs A; Levantini E; Baldwin AS Cancer Res; 2010 May; 70(9):3537-46. PubMed ID: 20406971 [TBL] [Abstract][Full Text] [Related]
9. Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model. Floyd HS; Farnsworth CL; Kock ND; Mizesko MC; Little JL; Dance ST; Everitt J; Tichelaar J; Whitsett JA; Miller MS Carcinogenesis; 2005 Dec; 26(12):2196-206. PubMed ID: 16051643 [TBL] [Abstract][Full Text] [Related]
10. An essential role for Rac in Ras transformation. Qiu RG; Chen J; Kirn D; McCormick F; Symons M Nature; 1995 Mar; 374(6521):457-9. PubMed ID: 7700355 [TBL] [Abstract][Full Text] [Related]
11. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. Allen TD; Rodriguez EM; Jones KD; Bishop JM Cancer Res; 2011 Sep; 71(18):6010-8. PubMed ID: 21803744 [TBL] [Abstract][Full Text] [Related]
12. Early requirement of Rac1 in a mouse model of pancreatic cancer. Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285 [TBL] [Abstract][Full Text] [Related]
13. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer. Jin K; Park S; Ewton DZ; Friedman E Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193 [TBL] [Abstract][Full Text] [Related]
14. Temporal dissection of K-ras(G12D) mutant in vitro and in vivo using a regulatable K-ras(G12D) mouse allele. Wang Z; Feng Y; Bardeesy N; Wong KK; Liu XY; Ji H PLoS One; 2012; 7(5):e37308. PubMed ID: 22606359 [TBL] [Abstract][Full Text] [Related]
15. Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas. Tran PT; Fan AC; Bendapudi PK; Koh S; Komatsubara K; Chen J; Horng G; Bellovin DI; Giuriato S; Wang CS; Whitsett JA; Felsher DW PLoS One; 2008 May; 3(5):e2125. PubMed ID: 18461184 [TBL] [Abstract][Full Text] [Related]
16. Rac1 and extracellularly regulated kinase activation are sufficient for E1A-dependent cooperative transformation of primary epithelial cells, but progression can only be modulated by E1A or Rac1. Fischer RS; Zheng Y; Quinlan MP Cell Growth Differ; 1998 Mar; 9(3):209-21. PubMed ID: 9543387 [TBL] [Abstract][Full Text] [Related]
17. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice. Wang Y; Zhang Z; Lubet RA; You M Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444 [TBL] [Abstract][Full Text] [Related]
18. Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis. Wang Y; Lebowitz D; Sun C; Thang H; Grynpas MD; Glogauer M J Bone Miner Res; 2008 Feb; 23(2):260-70. PubMed ID: 17922611 [TBL] [Abstract][Full Text] [Related]
19. Rac GTPase isoforms Rac1 and Rac2 play a redundant and crucial role in T-cell development. Guo F; Cancelas JA; Hildeman D; Williams DA; Zheng Y Blood; 2008 Sep; 112(5):1767-75. PubMed ID: 18579797 [TBL] [Abstract][Full Text] [Related]
20. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Khosravi-Far R; Solski PA; Clark GJ; Kinch MS; Der CJ Mol Cell Biol; 1995 Nov; 15(11):6443-53. PubMed ID: 7565796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]